4-(trifluoromethyl)phenol

Identification

Generic Name
4-(trifluoromethyl)phenol
DrugBank Accession Number
DB03610
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 162.1092
Monoisotopic: 162.029249397
Chemical Formula
C7H5F3O
Synonyms
  • 4-hydroxybenzotrifluoride
  • 4-trifluoromethylphenol
  • α,α,α-trifluoro-p-cresol
External IDs
  • SR-1C13

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as trifluoromethylbenzenes. These are organofluorine compounds that contain a benzene ring substituted with one or more trifluoromethyl groups.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Trifluoromethylbenzenes
Direct Parent
Trifluoromethylbenzenes
Alternative Parents
1-hydroxy-2-unsubstituted benzenoids / Organooxygen compounds / Organofluorides / Hydrocarbon derivatives / Alkyl fluorides
Substituents
1-hydroxy-2-unsubstituted benzenoid / Alkyl fluoride / Alkyl halide / Aromatic homomonocyclic compound / Hydrocarbon derivative / Organic oxygen compound / Organofluoride / Organohalogen compound / Organooxygen compound / Phenol
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
phenols, (trifluoromethyl)benzenes (CHEBI:42578)
Affected organisms
Not Available

Chemical Identifiers

UNII
G8PMO13PO4
CAS number
402-45-9
InChI Key
BAYGVMXZJBFEMB-UHFFFAOYSA-N
InChI
InChI=1S/C7H5F3O/c8-7(9,10)5-1-3-6(11)4-2-5/h1-4,11H
IUPAC Name
4-(trifluoromethyl)phenol
SMILES
OC1=CC=C(C=C1)C(F)(F)F

References

General References
Not Available
Human Metabolome Database
HMDB0014023
PubChem Compound
67874
PubChem Substance
46507301
ChemSpider
61191
ChEBI
42578
ChEMBL
CHEMBL539165
ZINC
ZINC000001847459
PDBe Ligand
FCR
PDB Entries
1e0y / 1e8g

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility5.06 mg/mLALOGPS
logP2.65ALOGPS
logP2.55Chemaxon
logS-1.5ALOGPS
pKa (Strongest Acidic)9.39Chemaxon
pKa (Strongest Basic)-6Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count1Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area20.23 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity34.01 m3·mol-1Chemaxon
Polarizability12.23 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+1.0
Blood Brain Barrier+0.9695
Caco-2 permeable+0.8351
P-glycoprotein substrateNon-substrate0.8196
P-glycoprotein inhibitor INon-inhibitor0.9623
P-glycoprotein inhibitor IINon-inhibitor0.9643
Renal organic cation transporterNon-inhibitor0.8931
CYP450 2C9 substrateNon-substrate0.8147
CYP450 2D6 substrateNon-substrate0.8429
CYP450 3A4 substrateNon-substrate0.6924
CYP450 1A2 substrateInhibitor0.541
CYP450 2C9 inhibitorNon-inhibitor0.8181
CYP450 2D6 inhibitorNon-inhibitor0.9415
CYP450 2C19 inhibitorNon-inhibitor0.5502
CYP450 3A4 inhibitorNon-inhibitor0.8232
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.8932
Ames testNon AMES toxic0.9293
CarcinogenicityNon-carcinogens0.7055
BiodegradationNot ready biodegradable0.9211
Rat acute toxicity2.0607 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9253
hERG inhibition (predictor II)Non-inhibitor0.907
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
GC-MS Spectrum - EI-BGC-MSsplash10-03di-3900000000-339a9867b26e7746d618
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-03di-0900000000-7cfe3e4d071b8df012cc
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-03di-0900000000-d3e7706036b9963ac162
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-00di-0900000000-a536d91f645e53f23afa
LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-03di-0900000000-35560d0bccacf0ffd839
LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-03di-0900000000-f580eb5c01ab9ddb2bb1
LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-03di-0900000000-b4d77ce106c256eb8df4
LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-03di-0900000000-69c3b8e6eb2a307a1db8
LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-03di-0900000000-7151172fbe144e973697
LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-03k9-0900000000-14fe650cfca3e3d760a5
LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-00di-2900000000-04df9943cb2057eddafa
LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-03di-0900000000-2929e9d9d1060925020d
LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-03di-0900000000-2929e9d9d1060925020d
LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-03di-0900000000-52ffec6a046f298ea507
LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-03di-0900000000-3c4094b0808488e5276f
LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-03k9-0900000000-efb307ad1e7e2eff56cc
LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-00di-1900000000-f052abaa52b1920f05c4

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52